European patent for smartphone diagnostic technology

Smartphone diagnostic specialist Novarum DX has achieved a significant milestone in the development of its revolutionary technology after being officially granted a European patent. Novarum has been awarded the patent for its smartphone diagnostic technology by the European Patent Office, having already secured the equivalent patent for its technology in the US earlier this year. … Continue reading European patent for smartphone diagnostic technology

Ken Skates opens new BBI Group headquarters in Crumlin

Economy Secretary Ken Skates has been in Crumlin to open the new £14m global headquarters of life sciences company, BBI Group. Following a £1.8m package of Welsh Government support, the company has chosen the Caerphilly town as the location for its new global headquarters. It has also centralised its manufacturing and development activities from sites … Continue reading Ken Skates opens new BBI Group headquarters in Crumlin

Takara launches lentivirus test using smartphone app

Takara Bio USA, Inc. (TBUSA, formerly Clontech Laboratories, Inc.) teamed up with smartphone diagnostics specialists, Novarum DX, to develop an integrated, mobile platform which detects and quantifies recombinant lentivirus in packaging cell supernatants. Novarum’s next generation diagnostic technology transforms a smartphone into a test reader to rapidly deliver accurate results without the need for large … Continue reading Takara launches lentivirus test using smartphone app

New ISO standard secured for Novarum medical device

Smartphone diagnostic specialist, Novarum DX, has been accredited with ISO 13485:2016 certification for Medical Device Quality Management Systems (QMS). Novarum DX transitioned from ISO 13485:2003, the internationally recognised Medical Device Quality Management System standard, to the new ISO 13485:2016 standard with zero non-conformances, ahead of the transition deadline in March 2019. To achieve certification, Novarum … Continue reading New ISO standard secured for Novarum medical device

BBI Group moves to new £14m headquarters

The Industrial Agency team of Knight Frank has brokered the sale of three properties for BBI Group. Insider Media reports it sold Units 6 and 15 at Gilchrist Thomas Industrial Estate in Blaenavon to GOS Tool & Engineering Services Ltd for £600,000 and an office and laboratory at Golden Gate, Llanishen, for £730,000. BBI Group, … Continue reading BBI Group moves to new £14m headquarters

New procalcitonin monoclonal antibodies

BBI Solutions has invested in the addition of three new monoclonal antibodies specific for procalcitonin (PCT). Detection of PCT in serum requires high levels of sensitivity to detect small shifts in the ng/mL range. These newly added antibodies have demonstrated detection in multiple matched pair combinations, with greater levels of sensitivity than a current commercially … Continue reading New procalcitonin monoclonal antibodies

Novarum US patent granted

Novarum DX has been officially granted a patent for their smartphone diagnostic technology in the US. Part of BBI Solutions, Novarum has developed image capture technology which transforms a smartphone into a diagnostic reader to deliver accurate test results, of lab quality, directly from the point of care. BBI Solutions reports the US patent (9,903,857) … Continue reading Novarum US patent granted

BBI Solutions acquires Maine Biotechnology Services

BBI Solutions has announced the addition of over eighty new antibodies to its growing product portfolio, as well as custom antibody development services following the acquisition of Maine Biotechnology Services (MBS) in Portland, Maine. BBI, a leading manufacturer of raw materials and finished test platforms, already provides human antigens, antibodies, serum and plasma products and … Continue reading BBI Solutions acquires Maine Biotechnology Services

More antibodies added to BBI Solutions’ portfolio

BBI Solutions has announced the launch of ten infectious disease markers, three inflammatory markers, two fertility markers and an additional cardiac marker. All the antibodies have been tested in either lateral flow or ELISA and are available for sampling. BBI Solutions is in a rapid period of expansion and growth with recent announcements of a … Continue reading More antibodies added to BBI Solutions’ portfolio

BBI Solutions increases capacity for cell culture native human transferrin production

BBI Solutions has invested in its facilities and resources to increase the capacity of cell culture transferrin production by up to 40% (Pharma Integrates, 2017). Stephane Argivier, BBI’s Director of Product Management, said “Demand for our cell culture grade transferrin was growing at such a rate that we had reached our full capacity. In response … Continue reading BBI Solutions increases capacity for cell culture native human transferrin production

Free WordPress Themes, Free Android Games